Dennis Slamon
MD, PhD
Director, Clinical/Translational Research, Jonsson Comprehensive Cancer Center
👥Biography 个人简介
Dennis Slamon at UCLA is internationally recognized for his discovery of HER2 amplification in breast cancer and development of trastuzumab, and has more recently contributed to CDK4/6 inhibitor development for HR-positive breast cancer. His translational research integrates molecular tumor profiling with targeted therapy development. He continues to investigate mechanisms of endocrine resistance and novel combination strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Dennis Slamon 的研究动态
Follow Dennis Slamon's research updates
留下邮箱，当我们发布与 Dennis Slamon（UCLA Jonsson Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment